| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |